Cargando…
Economic Burden and Quality of Life of Hepatocellular Carcinoma in Greater China: A Systematic Review
BACKGROUND: Hepatocellular carcinoma (HCC) accounts for more than 85%-90% of primary liver cancer globally, and approximately 45% of deaths from HCC occur in greater China. This disease poses a significant economic burden for patients, payers and society and significantly affects patients' qual...
Autores principales: | Zou, Huimin, Li, Meng, Lei, Qing, Luo, Zejun, Xue, Yan, Yao, Dongning, Lai, Yunfeng, Ung, Carolina Oi Lam, Hu, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068962/ https://www.ncbi.nlm.nih.gov/pubmed/35530735 http://dx.doi.org/10.3389/fpubh.2022.801981 |
Ejemplares similares
-
Budget Impact Analysis of Diabetes Drugs: A Systematic Literature Review
por: Luo, Zejun, et al.
Publicado: (2021) -
Comparative analysis of disease modelling for health economic evaluations of systemic therapies in advanced hepatocellular carcinoma
por: Zou, Huimin, et al.
Publicado: (2023) -
Economic Burden of Major Diseases in China in 2013
por: Song, Xianyan, et al.
Publicado: (2021) -
Pharmacoeconomic evaluation of anti-obesity drugs for chronic weight management: a systematic review of literature
por: Xue, Yan, et al.
Publicado: (2023) -
Clinical Outcomes Associated with Monotherapy and Combination Therapy of Immune Checkpoint Inhibitors as First-Line Treatment for Advanced Hepatocellular Carcinoma in Real-World Practice: A Systematic Literature Review and Meta-Analysis
por: Zou, Huimin, et al.
Publicado: (2022)